중동 및 아프리카 첨가제 시장 – 2030년까지의 산업 동향 및 예측

중동 및 아프리카 보조제 시장 분석 및 규모

다기능성 부형제의 기술적 발전은 예측 기간 동안 부형제 시장 성장을 위한 원동력으로 작용합니다. 약물 개발 프로세스의 장기간은 예측 기간 동안 부형제 시장을 방해할 것으로 예상됩니다. 시장 참여자의 전략적 이니셔티브는 부형제 시장 성장의 기회로 작용합니다. 보관 및 운송 시의 안전 고려 사항은 부형제 시장 성장에 대한 과제로 작용합니다. 그러나 비용과 시간이 많이 소요되는 약물 개발 프로세스는 중동 및 아프리카 제약 부형제 시장의 성장을 방해할 것으로 예상됩니다. 더욱이 보관 및 운송 시의 안전 고려 사항은 2023년에서 2030년 사이의 예측 기간 동안 시장 성장에 가장 크고 가장 중요한 과제가 될 것으로 예상됩니다.

Data Bridge Market Research는 2022년에 2억 3,723만 달러였던 보조제 시장이 2030년까지 3억 5,466만 달러로 급증할 것으로 분석했으며, 예측 기간 동안 5.2%의 CAGR을 경험할 것으로 예상합니다. 이는 시장 가치를 나타냅니다. "직접 입찰"은 보조제 유통의 주요 공급원이기 때문에 보조제 시장의 유통 채널 세그먼트를 지배합니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

중동 및 아프리카 보조제 시장 범위 및 세분화

시장 정의

부형제는 활성 약제 성분을 제외한 약물의 모든 것을 포함합니다 . 이 분자는 약효가 없으며 궁극적으로 약물의 생리적 흡수를 향상시키는 데 사용됩니다. 부형제는 본질적으로 불활성이며 약물 분자가 환자에게 올바른 형태로 적용될 수 있도록 합니다.

중동 및 아프리카 보조제 시장 동향

운전자

• 나노첨가제 개발 및 의약품 생산을 위한 나노기술 사용 증가

Nano-delivery systems and nanomedicine are new and rapidly growing fields where nanoscale materials are used to deliver therapeutic agents to targeted sites or as diagnostic tools. Nanotechnology provides several advantages in treating chronic human diseases through site-specific and selective delivery of accurate medicines. During the manufacturing of NADDS, the process has the potential to convert the excipients into nano-excipients. Nano-excipients have enhanced properties compared to excipients. Nano-excipients are easily transported through biological membranes. Also, they can easily get absorbed into the blood and delivered to the targeted tissue and cell. Nano-excipients stay in the circulatory system for a prolonged period and release the amalgamated drugs as per the specified dose. The efficient production of NADDS includes a detailed understanding of the physicochemical properties and functionality of the excipients. Thus, nanotechnology excipients would witness intensive scientific investigations in the coming years, as they can contribute unique functionality to drug products. This increase in use of nanotechnology for development of nano-excipients and in pharmaceutical drug production which will further act as driver that will lead to the growth of the excipients market in the above mentioned projected timeframe

• Rise in Technological Advancements in Multifunctional Excipients

Multifunctional excipients can be obtained by developing a new excipient (such as cross-linked polymers) or by developing new grades of existing excipients; modification in the processing leads to changes in the particle size distribution, particle shape and morphology and porosity. This increase in the technological advancements is expected to accelerate the market growth. Furthermore, most of the excipients are used in pharmaceutical and biopharmaceutical companies because these companies are responsible for the production of medicines in all dosage forms such as solid, semi-solid and liquid

• Rising Pharmaceutical Industry

Expanding pharmaceutical industry due to disruptive technologies and emerging trends such as robotics, artificial intelligence, 3d printing, precision medicine or patient design will impact the manufacturing and distribution of pharmaceuticals. In order to prepare successfully for a better future of healthcare, the pharma industry has to embrace new technologies and put a greater focus on prevention and digital health, which can foster the demand for the excipients in the market

Opportunity

• Rising Strategic Initiatives by Market Players

Furthermore, key product launches, high concentration of market players or manufacturer's presence, and acquisition and partnerships among major players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, the rising demand for drugs has significantly heightened the need for new drug development via extensive clinical trials. Manufacturers are now focusing on remodelling their drug development processes in an attempt to cater to patient needs. Increasing advancement in technology and rising number of innovations along with rising product approvals which will further contribute by generating immense opportunities that will further expand the market's growth rate in the future 

Restraint/Challenge

• Higher Cost and Time Intensive Drug Development Process

On the other hand, cost and time-intensive drug development process is expected to hinder the growth of Middle East and Africa pharmaceutical excipients market. The safety consideration in storage and transportation restraint the market. Moreover, cost of these developments will projected to become the biggest and foremost challenge for the growth of the market in the forecast period of 2023 to 2030

This excipients market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the excipients market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Recent Development

• In 2020, Evonik launched RESOMER Precise platform of custom functional excipients to precisely control the release profile of parenteral drug products

Middle East and Africa Excipients Market Scope

The excipients market is segmented on the basis of origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, and route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Origin

• Organic
• Inorganic

Category

• Primary Excipients
• Secondary Excipients

Products

• Polymers
• Sugars
• Alcohols
• Minerals
• Gelatin
• Others

Chemistry Type

• Plant
• Animals
• Synthetic
• Minerals

Chemical Synthesis

• Lactose Monohydrate
• Sucralose
• Polysorbate
• Benzyl Alcohol
• Cetosteary Alcohol
• Soy Lecithin
• Pregelatinized Starch
• Others

Functionality

• Binders and Adhesives
• Disintegrants
• Coating Material
• Disintegrants, Solubilizers
• Flavours
• Sweetening Agents
• Diluents
• Lubricants
• Buffers
• Emulsifying Agents
• Preservatives
• Antioxidants
• Sorbents
• Solvents
• Emollients
• Glidients
• Chelating Agents
• Antifoaming Agents
• Others

Dosage Form

• Solid
• Semi-Solid
• Liquid

Route of Administration

• Oral Excipients
• Topical Excipients
• Parenteral Excipients
• Other Excipients

End-User

• Pharmaceutical and Biopharmaceutical Companies
• Contract Formulators
• Research Organization and Academics
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Others

Middle East and Africa Excipients Market Regional Analysis/Insights

The excipients market is analysed and market size insights and trends are provided by origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, and route of administration, end-user and distribution channel.

The countries covered in the excipients market report are South Africa, Saudi Arabia, U.A.E., Israel, Kuwait, Egypt, and Rest of Middle East and Africa.

South Africa dominates the excipients market and is expected to grow at the highest growth rate during the forecast period of 2023 to 2030 due to innovations in biopharmaceuticals, rising focus on orphan drugs and technological advancements in multifunctional excipients.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The excipients market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for handheld ultrasound imaging devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the handheld ultrasound imaging devices market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Excipients market Share Analysis

보조제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 핸드헬드 초음파 영상 장치 시장과 관련된 회사의 초점에만 관련이 있습니다.

부형제 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Evonik Industries AG(독일)
• 크로다 인터내셔널 주식회사(영국)
• JRS Pharma(독일)
• 컬러콘(미국)
• Peter Greven GmbH & Co. KG(독일)
• 오미아 AG(스위스)
• ADM(미국)
• MEGGLE 그룹 Wasserburg(독일)
• 케리 그룹 PLC(아일랜드)
• Avantor, Inc (미국)

SKU-61260